AAIM
BMY.RT

American Assets Investment Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

American Assets Investment Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-29,000
Closed -$20K – 149
2020
Q4 		$20K Hold
29,000
– – ﹤0.01% 125
2020
Q3 		$65K Hold
29,000
– – 0.01% 120
2020
Q2 		$104K Hold
29,000
– – 0.02% 118
2020
Q1 		$110K Hold
29,000
– – 0.02% 167
2019
Q4 		$87K Buy
+29,000
New +$75.4K 0.01% 172

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

American Assets Investment Management's BMY.RT Position: Q1 2021 in Review

American Assets Investment Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 29,000 shares — an estimated $20K sold.

American Assets Investment Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $110K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • American Assets Investment Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • American Assets Investment Management sold 29,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $20K.
  • American Assets Investment Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • American Assets Investment Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $110K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on American Assets Investment Management's 13F filing for Q1 2021, filed 29 Apr 2021.